Get started
Author

Christoph Wanner

The German Chronic Kidney Disease (GCKD) study: design and methods
2011 · K.-U. Eckardt, B. Barthlein, et al. · Nephrology Dialysis Transplantation · 174
PDF
Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study
2014 · J. Jing, J. T. Kielstein, et al. · Nephrology Dialysis Transplantation · 126
Taming the chronic kidney disease epidemic: a global view of surveillance efforts
2014 · Jai Radhakrishnan, Giuseppe Remuzzi, et al. · Kidney International · 112
Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy
2008 · J. Galle, E. Schwedhelm, et al. · Nephrology Dialysis Transplantation · 94
The 2008 ERA-EDTA Registry Annual Report--a precis
2010 · V. S. Stel, M. W. M. van de Luijtgaarden, et al. · Clinical Kidney Journal · 92
PDF
Renal replacement therapy for rare diseases affecting the kidney: an analysis of the ERA-EDTA Registry
2014 · E. Wuhl, K. J. van Stralen, et al. · Nephrology Dialysis Transplantation · 84
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria
2025 · Brendon L. Neuen, Robert A. Fletcher, et al. · JAMA · 77
Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study
2020 · Caroline Morbach, Götz Gelbrich, et al. · European Journal of Preventive Cardiology · 48
PDF
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study
2013 · F. Locatelli, G. Spasovski, et al. · Nephrology Dialysis Transplantation · 30
PDF
The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk?
2010 · K. J. Jager, V. S. Stel, et al. · Nephrology Dialysis Transplantation · 26
PDF
Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement
2015 · D. Goldsmith, D. Goldsmith, et al. · Nephrology Dialysis Transplantation · 25
Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells
1993 · Annette Krämer, Matthias Nauck, et al. · Kidney International · 24
Renal replacement therapy in Europe--a summary of the 2009 ERA-EDTA Registry Annual Report
2012 · M. W. M. van de Luijtgaarden, M. Noordzij, et al. · Clinical Kidney Journal · 23
PDF
Impact of dyslipidaemia in renal transplant recipients
2000 · Christoph Wanner, Thomas Quaschning, et al. · Current Opinion in Urology · 22
Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
1996 · J Zimmermann, L Schramm, et al. · PubMed · 21
Potential role of lipids in the progression of diabetic nephropathy.
1996 · A Krämer-Guth, T Quaschning, et al. · PubMed · 16
Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
1997 · S Greiber, C Wanner · PubMed · 13
Lipoprotein(a) in renal patients: is it a key factor in the high cardiovascular mortality?
1994 · C. Wanner, W. Bartens · Nephrology Dialysis Transplantation · 11
Urinary proteinase activity in patients with multiple traumatic injuries, sepsis, or acute renal failure.
1986 · C Wanner, P Schollmeyer, et al. · PubMed · 11
Determinants and reference values of the 6-min walk distance in the general population—results of the population-based STAAB cohort study
2024 · Caroline Morbach, Nicola Moser, et al. · Clinical Research in Cardiology · 10
PDF
Causes of death in patients with chronic kidney disease: insights from the ASCEND-D and ASCEND-ND cardiovascular outcomes trials
2022 · A K Singh, A Acharya, et al. · European Heart Journal · 10
PDF
Uptake and metabolism of lipoproteins from patients with diabetes mellitus type II by glomerular epithelial cells
1997 · A. Kramer-Guth, T. Quaschning, et al. · Nephrology Dialysis Transplantation · 9
PDF
The nephrology crystal ball: the medium-term future
2019 · Carmine Zoccali, Peter J Blankestijn, et al. · Nephrology Dialysis Transplantation · 8
Causal assessment of CKD-MBD biomarker alterations on CKD progression through a g-formula analysis in the EQUAL study
2025 · Lorenza Magagnoli, Mario Cozzolino, et al. · Kidney International · 7
OPTA: Optimal treatment of anaemia in patients with chronic kidney disease (CKD)
2007 · W. H. Horl, Y. Vanrenterghem, et al. · Nephrology Dialysis Transplantation · 6
PDF
Works count: 41
Citation count: 1,095
H-index: 16
I10-index: 21
Year
Topic
Type